190

Allergy&Clinical immunology
Sub Categories on Allergy&Clinical immunology
Latest Articles
Rogue lipids: How routine cellular stress can fuel chronic inflammation

Rogue lipids: How routine cellular stress can fuel chronic inflammation

Rogue lipids: How routine cellular stress can fuel chronic inflammationby Delthia RicksCredit: Unsplash/CC0 Public DomainOxidized lipids—fats structurally altered by enzymes, oxygen or free radicals—a

Rogue lipids: How routine cellular stress can fuel chronic inflammation

Rogue lipids: How routine cellular stress can fuel chronic inflammationby Delthia RicksCredit: Unsplash/CC0 Public DomainOxidized lipids—fats structurally altered by enzymes, oxygen or free radicals—a
Of mice and zebrafish: How scientists solved a decades-old mystery and uncovered new insights about inflammation

Of mice and zebrafish: How scientists solved a decades-old mystery and uncovered new insights about inflammation

Of mice and zebrafish: How scientists solved a decades-old mystery and uncovered new insights about inflammationby Ian DemskyTiny, transparent, fast-growing—zebrafish are an ideal model organism for s

Of mice and zebrafish: How scientists solved a decades-old mystery and uncovered new insights about inflammation

Of mice and zebrafish: How scientists solved a decades-old mystery and uncovered new insights about inflammationby Ian DemskyTiny, transparent, fast-growing—zebrafish are an ideal model organism for s
Discovery explains how immune cells target DNA mutations to improve antibodies

Discovery explains how immune cells target DNA mutations to improve antibodies

Discovery explains how immune cells target DNA mutations to improve antibodiesCredit: Unsplash/CC0 Public DomainScientists at the Montreal Clinical Research Institute (IRCM), led by Université de Mont

Discovery explains how immune cells target DNA mutations to improve antibodies

Discovery explains how immune cells target DNA mutations to improve antibodiesCredit: Unsplash/CC0 Public DomainScientists at the Montreal Clinical Research Institute (IRCM), led by Université de Mont
Microbiome transplants may curb food allergies

Microbiome transplants may curb food allergies

Microbiome transplants may curb food allergiesSeptember 8, 2026Millions of people in the U.S. have food allergies, which can cause life-threatening symptoms. Growing evidence suggests the microbes, or

Microbiome transplants may curb food allergies

Microbiome transplants may curb food allergiesSeptember 8, 2026Millions of people in the U.S. have food allergies, which can cause life-threatening symptoms. Growing evidence suggests the microbes, or
International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseasesCredit: Unsplash/CC0 Public DomainAn international multidisciplinary group of 31 experts has updated

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseasesCredit: Unsplash/CC0 Public DomainAn international multidisciplinary group of 31 experts has updated
Retraining the immune system to treat type 1 diabetes

Retraining the immune system to treat type 1 diabetes

byUniversity of MissouriCredit:JCI Insight(2026). DOI: 10.1172/jci.insight.200686Type 1 diabetes (T1D) is a lifelong autoimmune disorder where the immune system attacks islets, certain areas of the pa

Retraining the immune system to treat type 1 diabetes

byUniversity of MissouriCredit:JCI Insight(2026). DOI: 10.1172/jci.insight.200686Type 1 diabetes (T1D) is a lifelong autoimmune disorder where the immune system attacks islets, certain areas of the pa
How cells clear immune signals could reshape drug design and cancer spread research

How cells clear immune signals could reshape drug design and cancer spread research

byUniversity of KonstanzCredit: Unsplash/CC0 Public DomainOur body receives and processes a vast number of signals. Chemical signals serve as guidance cues and ensure, for example, that immune cells a

How cells clear immune signals could reshape drug design and cancer spread research

byUniversity of KonstanzCredit: Unsplash/CC0 Public DomainOur body receives and processes a vast number of signals. Chemical signals serve as guidance cues and ensure, for example, that immune cells a
How cells fight infection from the inside: Newly identified ADX pathway may broaden understanding of immunity

How cells fight infection from the inside: Newly identified ADX pathway may broaden understanding of immunity

byCell PressSuper-resolution image of an LC3-positive autophagosome engulfing a TRIM21- and antibody-coated adenovirus. Credit: Claudia Puri, Matthew J. Gratian, Anna Albecka, and Tyler Rhinesmith.Whe

How cells fight infection from the inside: Newly identified ADX pathway may broaden understanding of immunity

byCell PressSuper-resolution image of an LC3-positive autophagosome engulfing a TRIM21- and antibody-coated adenovirus. Credit: Claudia Puri, Matthew J. Gratian, Anna Albecka, and Tyler Rhinesmith.Whe
Early immunotherapy aids in treating potentially fatal fungal pneumonias in preclinical models

Early immunotherapy aids in treating potentially fatal fungal pneumonias in preclinical models

byUniversity of Texas MD Anderson Cancer CenterHematoxylin & eosin-stained lung tissue sections according to the treatment arm, showing an absence of lymphocytic infiltrates, even in mice that rec

Early immunotherapy aids in treating potentially fatal fungal pneumonias in preclinical models

byUniversity of Texas MD Anderson Cancer CenterHematoxylin & eosin-stained lung tissue sections according to the treatment arm, showing an absence of lymphocytic infiltrates, even in mice that rec
New drug cuts relapse risk by half in rare immune disorder trial

New drug cuts relapse risk by half in rare immune disorder trial

by Sarah Williams,Stanford UniversityIn IgG4-related disease, B cells (above) attack the body's own tissue. A study led by Stanford Medicine has found that a drug reduces the chance of relapse. Cr

New drug cuts relapse risk by half in rare immune disorder trial

by Sarah Williams,Stanford UniversityIn IgG4-related disease, B cells (above) attack the body's own tissue. A study led by Stanford Medicine has found that a drug reduces the chance of relapse. Cr